Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Stopping death cold

M H Werner1

  • 1Laboratory of Chemical Physics, National Institute of Diabetes, Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892-0505, USA.

Structure (London, England : 1993)
|August 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The 201 Trial: a placebo-controlled randomized phase 2 study of safety and tolerance of the c-Abl kinase inhibitor risvodetinib in untreated Parkinson's disease.

Nature aging·2026
Same author

[Morality, ethics and public health: philosophy and the challenge of pluralism].

Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz·2009
Same author

FADD self-association is required for stable interaction with an activated death receptor.

Cell death and differentiation·2006
Same author

ELA2 is regulated by hematopoietic transcription factors, but not repressed by AML1-ETO.

Oncogene·2005
Same author

[Conclusions from the Viagra case? Definition of disease in social legislation as exemplified by erectile dysfunction].

Gesundheitswesen (Bundesverband der Arzte des Offentlichen Gesundheitsdienstes (Germany))·2002
Same author

Flipping a genetic switch by subunit exchange.

The EMBO journal·2001
Same journal

Cryo-EM structure of the Arabidopsisthaliana ribosome in translating and non-translating states.

Structure (London, England : 1993)·2026
Same journal

Multifaceted effects of N-glycosylation on amyloidogenic κ light chains in AL amyloidosis.

Structure (London, England : 1993)·2026
Same journal

Near-complete cryo-EM structure of the Klebsiella pneumoniae podophage RAN69 reveals tail fiber-spike interface and a divergent pre-ejectosome.

Structure (London, England : 1993)·2026
Same journal

Saxiphilin is a broad-spectrum toxin sponge for C13-modified saxitoxins.

Structure (London, England : 1993)·2026
Same journal

Cryo-EM structure of YfdQ reveals a widespread family of bacteriophage-associated proteins with shell-like assemblies.

Structure (London, England : 1993)·2026
Same journal

An extracellular allosteric gate modulates the ligand efficacy of GPR119.

Structure (London, England : 1993)·2026
See all related articles

The 3D structure of Bcl-xL, an apoptosis inhibitor, reveals how protein combinations regulate cell death. This finding offers insights into controlling apoptosis through protein family interactions.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Apoptosis, or programmed cell death, is crucial for development and tissue homeostasis.
  • Bcl-xL is a key regulator of the intrinsic apoptosis pathway, inhibiting cell death.
  • Understanding the structural basis of Bcl-xL function is vital for therapeutic development.

Purpose of the Study:

  • To elucidate the three-dimensional structure of Bcl-xL.
  • To investigate how Bcl-xL interacts with other proteins to regulate apoptosis.
  • To provide structural insights into the control of apoptosis by protein families.

Main Methods:

  • X-ray crystallography was used to determine the 3D structure of Bcl-xL.
  • Structural analysis and comparison with related proteins were performed.

Related Experiment Videos

  • Bioinformatic tools were employed to predict protein interactions.

    • Main Results:

    • The high-resolution 3D structure of Bcl-xL was determined.
    • Structural features suggest mechanisms for differential protein binding.
    • The findings highlight the potential for varied protein family compositions to modulate apoptosis.

    Conclusions:

    • The structure of Bcl-xL provides a molecular basis for its inhibitory function in apoptosis.
    • Protein family members can be combined in different ways to fine-tune apoptosis control.
    • This structural knowledge can inform the design of novel therapeutics targeting apoptosis.